Therefore, in this study we measured serum NDKA using a sensitive method such as ELISA in a case -control cohort, and in an asymptomatic screening population with family history of CRC that included diverse colorectal pathologies, to evaluate the diagnostic capability of this biomarker to detect advanced neoplasia (AN: CRC or AA). Here, NME1 is linked to colorectal carcinoma.